Even after yet another lengthy absence, Jon Jones remains one of the Ultimate Fighting Championship’s biggest draws outside of Conor McGregor, Ronda Rousey and Brock Lesnar.
According to a report from MMAFighting.com, UFC 232 sold an estimated 700,000 pay-per-view buys between television and streaming purchases. If that figure holds up, it would be the promotion’s second-largest number of 2018 behind only UFC 229, which featured a Khabib Nurmagomedov vs. Conor McGregor headliner and drew an estimated 2.4 million buys. The Las Vegas-based organization does not release official pay-per-view buy rates to the public.
UFC 232 took place at the Forum in Inglewood, Calif., on Dec. 29 and saw Jones defeat Alexander Gustafsson for the vacant light heavyweight strap in the evening’s main event. The card was moved from Las Vegas to California after the Nevada Athletic Commission declined to license Jones due to abnormalities in the fighter’s drug test. “Bones” was allowed to compete by the California State Athletic Commission because it was determined that the trace elements of the anabolic steroid in his system were remnants of his failed drug test in July 2017.
The card also featured one of the most intriguing women’s bouts in UFC history in the co-main event, as Amanda Nunes knocked out Cristiane Justino in the opening stanza to become a two-division champion.